Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract—Quantifying the misclassification of maternal drug exposure during pregnancy
Authors:
- 9 September 2020
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 29 (11) , 1414-1422
Abstract
Purpose: Accurate ascertainment of gestational age (GA) has been a challenge in perinatal epidemiologic research. To date, no study has validated GA algorithms in Medicaid Analytic eXtract (MAX).Methods: We linked livebirths of mothers enrolled in Medicaid ≥30 days after delivery in 1999‐2010 MAX to state birth certificates. We used clinical/obstetric estimate of gestation on the birth certificates as gold standard to validate claims‐based GA algorithms. We calculated the proportions of deliveries with algorithm‐estimated GA within 1−/2‐weeks of the gold standard, the sensitivity, specificity, and positive/negative predictive value (PPV/NPV) of exposure to select medications during specific gestation windows, and quantified the impact of exposure misclassification on hypothetical relative risk (RR) estimates.Results: We linked 1 336 495 eligible deliveries. Within 1‐week agreement was 77%‐80% overall and 47%‐56% for preterm deliveries. The trimester‐specific drug exposure status had high sensitivities and PPVs (88.5%‐98.5%), and specificities and NPVs (>99.0%). Assuming a hypothetical RR of 2.0, bias associated with exposure misclassification during first trimester ranged from 10% to 40% under non‐differential/differential misclassification assumptions.Conclusions: Claims‐based GA algorithms had good agreement with the gold standard overall, but lower agreement among preterm deliveries, potentially resulting in biased risk estimated for pregnancy exposure evaluations.Keywords
This publication has 25 references indexed in Scilit:
- Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation resultsPharmacoepidemiology and Drug Safety, 2015
- Enrolling Pregnant Women: Issues in Clinical ResearchWomen's Health Issues, 2013
- Investigating outcomes associated with medication use during pregnancy: A review of methodological challenges and observational study designsReproductive Toxicology, 2012
- Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancyEuropean Journal of Clinical Pharmacology, 2011
- Clinical Research Enrolling Pregnant Women: A Workshop SummaryJournal of Women's Health, 2011
- The Role of Medicaid in Promoting Access to High-Quality, High-Value Maternity CareWomen's Health Issues, 2010
- Promise and pitfalls of administrative data in evaluating pregnancy outcomesPharmacoepidemiology and Drug Safety, 2007
- Epidemiologic Measures of the Course and Outcome of PregnancyEpidemiologic Reviews, 2002
- Identifying critical windows of exposure for children's health.Environmental Health Perspectives, 2000
- Timing and Patterns of Exposures during Pregnancy and Their Implications for Study MethodsAmerican Journal of Epidemiology, 1996